Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial

John A Liu Yin, Michelle A O'Brien, Robert K Hills, Sarah B Daly, Keith Wheatley, Alan K Burnett

Research output: Contribution to journal › Article › peer-review

249 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Minimal residual disease monitoring by quantitative RT-PCR in core binding factor AML allows risk stratification and predicts relapse: results of the United Kingdom MRC AML-15 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry